Browse Category

ASX:CSL 2 February 2026 - 26 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

CSL Limited (ASX:CSL) Stock Ends Week Down 7.4% as HEMGENIX Progress Faces Scale Test

CSL Limited enters Monday after five straight losses erased 7.4% from its share price, Friday-to-Friday. Shares closed Friday at A$114.22, down 1.3% on the day. The ASX cash market was closed at publication; pre-open begins at 07:00 AEST.

26 July 2026

ASX:CSL·Biotechnology·Pharmaceuticals·Stock Market

CSL (ASX:CSL) shares rebound A$16 billion off lows, lag plasma sector for week

CSL Limited has regained roughly A$16 billion in market value from its 52-week low, but last week's slight rise lagged behind two competitors involved in plasma.

19 July 2026

ASX Updates·ASX:CSL·Stock Market

CSL Limited (ASX:CSL) awaits US$650 million hurdle ahead of August results, pressuring rebound

CSL Limited gained 1.12% to close at A$123.32 on Friday. The S&P/ASX 200 index slipped 0.50%. Sydney’s cash market remained closed on Saturday morning.

18 July 2026

ASX News·ASX:CSL·Biotechnology·Earnings Reports·Stock Market

CSL Share Price Has Won Back A$15 Billion — Now Investors Want Revenue Proof

CSL Limited entered Tuesday’s ASX pre-open after falling 1.26% to A$121.34 on Monday, while the S&P/ASX 200 edged 0.03% higher. Turnover reached 1.50 million shares, 34% above the average of the previous five sessions. The exchange remained in pre-open at publication, with continuous trading due to begin around 10 a.m. Sydney time.

14 July 2026

ASX:CSL·Earnings Reports·Stock Market

Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks

Australian stocks took a hard hit last week, with the S&P/ASX 200 tumbling 3.8% amid escalating concerns over the Middle East conflict. Investors saw around A$130 billion in value erased from the market. On Friday, the index sank another 1%, which wiped out close to half the gains made in February.

7 March 2026

ASX:BHP·ASX:CBA·ASX:CSL·Stock Market

CSL share price ticks up on buyback update as investors line up key March dates

CSL Limited settled 0.5% higher at A$146.76 Friday, having swung from A$145.07 to A$147.53 through the session as roughly 1.68 million shares traded. The stock finished just about A$2 clear of its 52-week low at A$144.61, according to data.

27 February 2026

ASX:CSL·Share Buybacks·Stock Market

CSL share price slips again as buyback rolls on, March dividend date looms

CSL Ltd closed down 1.5% on Tuesday at A$145.13, slipping from an open of A$148.10 before ending the day on the session’s low. The stock has now dropped 5.3% across the last two sessions.

24 February 2026

ASX:CSL·Dividends

CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL Ltd slipped 0.6% Friday, ending the session at A$153.27. That pullback shaved off some of the gains from a two-day run-up earlier in the week.

20 February 2026

ASX:CSL·NYSE:LLY·Pharmaceutical Industry·Share Buybacks·Stock Market

CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background

CSL Ltd jumped up to 2.1% on Wednesday after the Australian biotech signed a licensing agreement with Eli Lilly for clazakizumab, an investigational antibody currently in trials for end-stage kidney disease.

18 February 2026

ASX:CSL·Pharmaceuticals·Stock Market

CSL share price slips after fresh buyback filing — what investors watch next

CSL Limited slipped 0.4% to finish at A$151.56 on Tuesday, lagging behind the S&P/ASX 200’s 0.2% gain. The stock has lost roughly 14% since early February, hit by a steep drop during profit season.

17 February 2026

ASX:CSL·Share Buybacks·Stock Market

ASX 200 today: Australian shares finish flat as AI fears hit insurers; CSL slides 5%

Australian stocks closed almost flat Tuesday, the S&P/ASX 200 shedding just 2.7 points, or 0.03%, to settle at 8,867.40. Insurance brokers took a hit as renewed AI competition fears surfaced. Miners, gold names, and tech all moved higher. “A peer releasing an app has wiped billions off the market capitalisations of the insurance broking sector,” said Luke Winchester, portfolio manager at Merewether Capital.

10 February 2026

ASX:ASX·ASX:CBA·ASX:CSL·NASDAQ:WLTW·NYSE:AJG·NYSE:AON·Stock Market

CSL CEO exit jolts ASX even as Nvidia lifts tech mood

CSL shares slid 4.98% Tuesday after the Australian biotech announced CEO Paul McKenzie’s retirement and tapped director Gordon Naylor as interim chief, effective Feb. 11. The S&P/ASX 200, which spent much of the day in positive territory, ended almost flat—off 0.03% at 8,867.4.

10 February 2026

ASX:CSL·Stock Market·Technology

CSL CEO Paul McKenzie retires ahead of results, sending shares lower as Gordon Naylor steps in

CSL announced Tuesday that chief executive and managing director Paul McKenzie is stepping down. Gordon Naylor, a veteran executive at the company, will assume the interim CEO role starting Feb. 11.

10 February 2026

ASX:CSL·Pharmaceuticals·Stock Market

CSL share price rises as CEO McKenzie steps down, spotlight turns to half-year results

CSL Ltd announced chief executive Paul McKenzie’s retirement, tapping former executive Gordon Naylor as interim replacement. Shares in CSL ended Tuesday 1.7% higher at A$183.44.

10 February 2026

ASX:CSL·Earnings Reports·Stock Market

CSL share price in focus after ASX sell-off: what investors watch before Feb 11 results

CSL Limited slipped 0.4% to finish at A$180.50 on Friday, with the ASX healthcare giant showing limited action as investors wait for its half-year results next week. Shares moved between A$179.29 and A$183.31 during the session.

7 February 2026

ASX News·ASX:CSL·Earnings Reports·Stock Market

Australia stock market today: ASX 200 slumps 2% as miners and tech drag, earnings week looms

Australian shares plunged on Friday, with the S&P/ASX 200 dropping 2.03% to 8,708.80. Web Travel Group took a heavy hit, tumbling 29.52%, and Paladin Energy slid 10.92%. Brambles was one of the few bright spots, edging up 3.48% amid a sparse field of winners.

6 February 2026

ASX:BXB·ASX:CBA·ASX:CSL·ASX:PDN·ASX:RIO·ASX:WEB·Earnings Reports·Stock Market

CSL share price dips in ASX rout — here’s what investors are watching before earnings

CSL Limited slipped 0.41% to finish at A$180.50 on Friday, with intraday trading ranging from A$179.29 to A$183.30. Roughly 1.23 million shares were exchanged, compared to a prior close of A$181.24, according to data from Investing.com.

6 February 2026

ASX News·ASX:CSL·Earnings Reports·Stock Market

CSL Limited share price rises 2% on ASX — what to know ahead of Feb 11 results

CSL Limited’s shares climbed 2.0% to close at A$181.70 on Wednesday, adding A$3.59. The stock fluctuated between A$182.04 at its peak and A$176.59 at its low during the session. Over the last 52 weeks, the price has ranged from A$168.00 to A$275.79.

4 February 2026

ASX:CSL·Earnings Reports

CSL shares bounce after Monday dip as investors eye Feb 11 results — what matters now

CSL Limited shares climbed 0.58% to close at A$178.11 on Tuesday, bouncing back after a 2.39% fall in the previous session. The broader S&P/ASX 200 index gained 0.89%. The stock fluctuated between A$177.93 and A$179.91, with the last trade occurring shortly after the market closed.

3 February 2026

ASX:CSL·Earnings Reports·Stock Market

CSL share price drops 2.4% as investors turn to Feb 11 half-year results webcast

CSL Limited shares dropped 2.39% to close at A$177.08 on Monday, hitting a low of A$176.18 after opening at A$182.00. The stock remains roughly 36% off its 52-week peak, with around 1.01 million shares traded.

2 February 2026

ASX:CSL·Earnings Reports·Stock Market

1 2 3 4 Next

ASX:CSL 2 February 2026 - 26 July 2026

CSL Limited (ASX:CSL) Stock Ends Week Down 7.4% as HEMGENIX Progress Faces Scale Test

CSL (ASX:CSL) shares rebound A$16 billion off lows, lag plasma sector for week

CSL Limited (ASX:CSL) awaits US$650 million hurdle ahead of August results, pressuring rebound

CSL Share Price Has Won Back A$15 Billion — Now Investors Want Revenue Proof

Australian Securities Exchange Weekly Wrap: ASX 200 Sheds A$130 Billion as Middle East War and Rate Risks Rattle Stocks

CSL share price slips again as buyback rolls on, March dividend date looms

CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background

ASX 200 today: Australian shares finish flat as AI fears hit insurers; CSL slides 5%

CSL CEO exit jolts ASX even as Nvidia lifts tech mood

CSL CEO Paul McKenzie retires ahead of results, sending shares lower as Gordon Naylor steps in

CSL share price rises as CEO McKenzie steps down, spotlight turns to half-year results

CSL share price in focus after ASX sell-off: what investors watch before Feb 11 results

Australia stock market today: ASX 200 slumps 2% as miners and tech drag, earnings week looms

CSL share price dips in ASX rout — here’s what investors are watching before earnings

CSL Limited share price rises 2% on ASX — what to know ahead of Feb 11 results

CSL shares bounce after Monday dip as investors eye Feb 11 results — what matters now

CSL share price drops 2.4% as investors turn to Feb 11 half-year results webcast

TechStock² Updates

Lockheed Martin Corporation (NYSE:LMT) Shares Lag Missile Demand Surge as Focus Turns to Cash Conversion

Super Micro Computer (NASDAQ:SMCI) Confronts Cash-Conversion Challenge Amid $60 Billion in Orders

The Trade Desk (NASDAQ:TTD) plunges 22% after Q3 outlook signals 12% revenue fall

NVIDIA Corporation (NASDAQ:NVDA) Stock Adds $562 Billion as Investors Reprice Growth

Apple (NASDAQ:AAPL), Samsung (KRX:005930) high-end smartphones make up an estimated 24% of global units

Top Stock Picks

AerCap

Constellation Energy

Cheniere Energy

Walt Disney

AIG

Live updates

Investment Disclaimer